VIMRxyn hypericin antiviral: Began Phase I/II trial in 24 HIV-infected patients in Thailand to identify an orally effctive dose with minimal skin phototoxicity.

VIMRx Pharmaceuticals Inc. (VMRX), Stamford, Conn.

Read the full 68 word article

How to gain access

Continue reading with a
two-week free trial.